CBYL - Kalvista Pharmaceuticals, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - CBYL (1348911)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
54 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2024-02-20
KALVFeener Edward P.Chief Scientific OfficerS - Sale+OE$14.07-28,28862,157-31%-$397,929
D
2024-02-20
KALVYea ChristopherChief Development OfficerS - Sale+OE$14.11-12,05372,895-14%-$170,124
D
2024-02-20
KALVPalleiko Benjamin LCFO, CBOS - Sale+OE$14.11-22,802187,315-11%-$321,846
D
2024-02-20
KALVAudhya Paul K.Chief Medical OfficerS - Sale+OE$14.12-14,29552,886-21%-$201,774
D
2024-02-20
KALVCrockett Thomas AndrewCEOS - Sale+OE$14.11-24,888211,203-11%-$351,289
2024-02-14
KALVPalleiko Benjamin LCFO, CBOS - Sale$15.01-40,855159,088-20%-$613,205
2024-02-14
KALVCrockett Thomas AndrewCEOS - Sale$15.01-58,356181,676-24%-$875,883
2024-02-14
KALVFeener Edward P.Chief Scientific OfficerS - Sale$15.01-28,17171,657-28%-$422,827
2024-02-14
KALVYea ChristopherChief Development OfficerS - Sale$15.01-39,88666,160-38%-$598,661
M
2024-02-06
KALVVenrock Healthcare Capital Partners Iii, L.P.10%P - Purchase$14.62+86,0484,824,731+2%+$1,257,829
2024-02-01
KALVCrockett Thomas AndrewCEOS - Sale$16.22-10,000117,532-8%-$162,198
2024-01-30
KALVVenrock Healthcare Capital Partners Iii, L.P.10%P - Purchase$14.47+88,0994,738,683+2%+$1,274,793
M
2024-01-25
KALVVenrock Healthcare Capital Partners Iii, L.P.10%P - Purchase$14.05+91,8044,650,584+2%+$1,289,802
M
2024-01-22
KALVVenrock Healthcare Capital Partners Iii, L.P.10%P - Purchase$12.53+99,1294,558,780+2%+$1,241,685
M
2024-01-17
KALVVenrock Healthcare Capital Partners Iii, L.P.10%P - Purchase$12.55+143,6054,459,651+3%+$1,801,602
M
2024-01-11
KALVVenrock Healthcare Capital Partners Iii, L.P.10%P - Purchase$12.72+26,2464,316,046+1%+$333,779
2024-01-11
KALVFeener Edward P.Chief Scientific OfficerS - Sale$13.03-22,67939,828-36%-$295,514
M
2024-01-08
KALVVenrock Healthcare Capital Partners Iii, L.P.10%P - Purchase$12.54+137,7004,289,800+3%+$1,726,457
M
2024-01-08
KALVFeener Edward P.Chief Scientific OfficerS - Sale$13.01-17,32162,507-22%-$225,300
M
2024-01-03
KALVVenrock Healthcare Capital Partners Iii, L.P.10%P - Purchase$12.14+59,3694,152,100+1%+$720,543
M
2023-12-27
KALVVenrock Healthcare Capital Partners Iii, L.P.10%P - Purchase$12.46+519,0174,092,731+15%+$6,465,650
2023-12-27
KALVCrockett Thomas AndrewCEOS - Sale$12.02-30,000127,532-19%-$360,453
D
2023-11-20
KALVAudhya Paul K.Chief Medical OfficerS - Sale+OE$8.23-7,98536,568-18%-$65,711
D
2023-11-20
KALVFeener Edward P.Chief Scientific OfficerS - Sale+OE$8.23-4,95879,828-6%-$40,801
D
2023-11-20
KALVYea ChristopherChief Development OfficerS - Sale+OE$8.23-7,11346,046-13%-$58,535
D
2023-11-20
KALVPalleiko Benjamin LPres, CFO, CBO, Sec'yS - Sale+OE$8.23-13,008112,443-10%-$107,047
D
2023-11-20
KALVCrockett Thomas AndrewCEOS - Sale+OE$8.23-14,807157,532-9%-$121,851
D
2023-09-11
KALVCha AlbertDirS - Sale+OE$10.50-18,0000-100%-$189,050
D
2023-08-18
KALVAudhya Paul K.Chief Medical OfficerS - Sale+OE$10.73-8,02026,023-24%-$86,045
D
2023-08-18
KALVFeener Edward P.Chief Scientific OfficerS - Sale+OE$10.73-4,97673,289-6%-$53,386
D
2023-08-18
KALVYea ChristopherChief Development OfficerS - Sale+OE$10.73-7,14241,662-15%-$76,624
D
2023-08-18
KALVPalleiko Benjamin LPres, CFO, CBO, Sec'yS - Sale+OE$10.73-13,06795,254-12%-$140,192
D
2023-08-18
KALVCrockett Thomas AndrewCEOS - Sale+OE$10.73-14,876146,756-9%-$159,602
D
2023-05-18
KALVYea ChristopherChief Development OfficerS - Sale+OE$10.14-2,60437,310-7%-$26,416
D
2023-05-18
KALVPalleiko Benjamin LPres, CFO, CBO, Sec'yS - Sale+OE$10.14-4,03778,126-5%-$40,953
D
2023-05-18
KALVFeener Edward P.Chief Scientific OfficerS - Sale+OE$10.14-1,78666,771-3%-$18,118
D
2023-05-18
KALVCrockett Thomas AndrewCEOS - Sale+OE$10.14-5,627128,050-4%-$57,083
D
2023-05-18
KALVAudhya Paul K.Chief Medical OfficerS - Sale+OE$10.14-2,78013,014-18%-$28,201
D
2023-02-17
KALVAudhya Paul K.Chief Medical OfficerS - Sale+OE$7.66-3,4129,347-27%-$26,136
D
2023-02-17
KALVFeener Edward P.Chief Scientific OfficerS - Sale+OE$7.66-2,22864,352-3%-$17,066
D
2023-02-17
KALVYea ChristopherChief Development OfficerS - Sale+OE$7.66-2,72735,709-7%-$20,889
D
2023-02-17
KALVPalleiko Benjamin LPres, CFO, CBO, Sec'yS - Sale+OE$7.66-4,95472,799-6%-$37,948
D
2023-02-17
KALVCrockett Thomas AndrewCEOS - Sale+OE$7.66-6,700120,927-5%-$51,322
D
2022-11-18
KALVYea ChristopherChief Development OfficerS - Sale+OE$5.44-1,13934,232-3%-$6,196
D
2022-11-18
KALVPalleiko Benjamin LCFO, CBO, SecretaryS - Sale+OE$5.44-72268,390-1%-$3,928
D
2022-11-18
KALVFeener Edward P.Chief Scientific OfficerS - Sale+OE$5.44-53062,376-1%-$2,883
D
2022-11-18
KALVCrockett Thomas AndrewCEOS - Sale+OE$5.44-1,785114,878-2%-$9,710
D
2022-11-18
KALVAudhya Paul K.Chief Medical OfficerS - Sale+OE$5.44-7225,946-11%-$3,928
2022-09-02
KALVCrockett Thomas AndrewCEOS - Sale$17.01-1,320110,858-1%-$22,458
D
2022-08-17
KALVAudhya Paul K.Chief Medical OfficerS - Sale+OE$14.96-7251,693-30%-$10,847
D
2022-08-17
KALVFeener Edward P.Chief Scientific OfficerS - Sale+OE$14.96-53261,132-1%-$7,960
D
2022-08-17
KALVYea ChristopherChief Development OfficerS - Sale+OE$14.96-1,14533,597-3%-$17,130
D
2022-08-17
KALVPalleiko Benjamin LCFO, CBO, SecretaryS - Sale+OE$14.96-72566,693-1%-$10,847
D
2022-08-17
KALVCrockett Thomas AndrewCEOS - Sale+OE$14.96-1,797112,178-2%-$26,890

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top